Document Type

Patent

Abstract

This process relates to a pharmaceutical composition of an Na—K-ATPase ligand which will stimulate Na/K-ATPase signaling in a pharmaceutically acceptable vehicle. In one embodiment, the composition may be used to treat a skin disorder. In another embodiment, the composition may be used to inhibit cardiac fibrosis.

Patent Country

US

Patent Number

US8906891

Publication Date

12-9-2014

Assignee(s)

The University of Toledo

Application Number

12/087976

Filing Date

January 2007

Primary Class

514/175

Secondary Class

514/25; 514/61

Rights

These materials are free of copyright restrictions and are in the public domain within the United States only. The USPTO reserves the right to assert copyright protection internationally.

Institution

The University of Toledo

Repository

University of Toledo Libraries

Digital Publisher

Digital Initiatives

Share

COinS